David B. Elsbree, Director at T2 Biosystems, Inc. (TTOO), bought 10,000 shares at $5.97 ($60K) on 2017-03-15, disclosed to the SEC on 2017-03-17.
Open-market purchase of $60k TTOO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| TTOO | SELL | 2019-06-13 | $5K | — | Filing → |
| TTOO | BUY | 2018-06-05 | $32K | — | Filing → |
| TTOO | BUY | 2017-11-17 | $6K | — | Filing → |